INSUBCONTINENT EXCLUSIVE:
Manas Jaiswal of manasjaiswal.com has a sell call on Sun Pharmaceutical Industries Ltd
with a target price of Rs 545
The current market price of Sun Pharmaceutical Industries Ltd
Time period given by the analyst is Intra Day when Sun Pharmaceutical Industries Ltd
price can reach the defined target
Manas Jaiswal recommended to keep stoploss at Rs 593
Sun Pharmaceutical Industries Ltd., incorporated in 1993, is a largecap with a market cap of Rs 138273.08 crore.
Sun Pharmaceutical
key Products/Revenue Segments include Pharmaceuticals which contributed Rs 7696.33 Crore to Sales Value (96.83 % of Total Sales) and Other
Operating Revenue which contributed Rs 251.27 Crore to Sales Value (3.16 % of Total Sales)for the year ending 31-Mar-2018
For the quarter ended 30-06-2018, the company has reported a Consolidated sales of Rs 7138.83 Crore, up 6.37 % from last quarter Sales of
Rs 6711.01 Crore and up 15.76 % from last year same quarter Sales of Rs 6166.66 Crore Company has reported net profit after tax of Rs
1110.05 Crore in latest quarter
Mr.Keki M Mistry, Mr.S Mohanchand Dadha, Mr.Sailesh T Desai, Mr.Sudhir V Valia, Mr.Vivek Chaand Sehgal, Ms.Rekha Sethi
LLP as its auditoRs As on 30-09-2018, the company has a total of 2,399,324,674 shares outstanding.
